読み込み中
Vivos Therapeutics, Inc. operates as a medical technology company that develops and commercializes treatment modalities for patients with dentofacial abnormalities, obstructive sleep apnea (OSA), and snoring in adults. It offers The Vivos Method, a non-invasive, non-surgical, non-pharmaceutical, multi-disciplinary treatment modality for the treatment of dentofacial abnormalities, OSA, and snoring. The company also offers VivoScore Program, a screening and home sleep test in adults and children. It markets and sells its appliances, and related treatments and services to licensed professionals, primarily general dentists in the United States and Canada. The company was formerly known as Vivos BioTechnologies, Inc. and changed its name to Vivos Therapeutics, Inc. in March 2018. The company was founded in 2016 and is based in Littleton, Colorado.
前日終値
$0.1311
−$0.0117 · -8.19%
日中の時刻はETです。市場データは遅延する場合があります。
Vivos Therapeutics, Inc. operates as a medical technology company that develops and commercializes treatment modalities for patients with dentofacial abnormalities, obstructive sleep apnea (OSA), and snoring in adults. It offers The Vivos Method, a non-invasive, non-surgical, non-pharmaceutical, multi-disciplinary treatment modality for the treatment of dentofacial abnormalities, OSA, and snoring. The company also offers VivoScore Program, a screening and home sleep test in adults and children. It markets and sells its appliances, and related treatments and services to licensed professionals, primarily general dentists in the United States and Canada. The company was formerly known as Vivos BioTechnologies, Inc. and changed its name to Vivos Therapeutics, Inc. in March 2018. The company was founded in 2016 and is based in Littleton, Colorado.
日中レンジ
現在 $0.1311
52週レンジ
現在 $0.1311
日中の時刻はETです。市場データは遅延する場合があります。
GoAI スコア
売り
バリュエーション
67
割安
センチメント
59
まちまち
リスク
96
極めて高いリスク
モメンタム
17
強い下落
GoAIの詳細リサーチ
詳しい根拠、カタリスト、リスクを確認できます。
Vivos Therapeutics, Inc. operates as a medical technology company that develops and commercializes treatment modalities for patients with dentofacial abnormalities, obstructive sleep apnea (OSA), and snoring in adults. It offers The Vivos Method, a non-invasive, non-surgical, non-pharmaceutical, multi-disciplinary treatment modality for the treatment of dentofacial abnormalities, OSA, and snoring. The company also offers VivoScore Program, a screening and home sleep test in adults and children. It markets and sells its appliances, and related treatments and services to licensed professionals, primarily general dentists in the United States and Canada. The company was formerly known as Vivos BioTechnologies, Inc. and changed its name to Vivos Therapeutics, Inc. in March 2018. The company was founded in 2016 and is based in Littleton, Colorado.
日中レンジ
現在 $0.1311
52週レンジ
現在 $0.1311
利用可能な期間全体で報告されたマージン。
売上高
営業利益
純利益
| 指標（USD） | 2025年度 | 2024年度 | 2023年度 | 2022年度 | 2021年度 |
|---|---|---|---|---|---|
| 売上高 | 1744.3万 USD | 1503.1万 USD | 1380.1万 USD | 1602.4万 USD | 1688.5万 USD |
| 売上原価 | 690.1万 USD | 601.2万 USD | 553万 USD | 600.5万 USD | 428.1万 USD |
| 粗利益 | 1054.2万 USD | 901.9万 USD | 827.1万 USD | 1001.9万 USD | 1260.4万 USD |
| 販売・一般管理 | 2912.7万 USD | 1960.9万 USD | 2494.6万 USD | 3438.1万 USD | 3134.2万 USD |
| 営業費用 | 3043.6万 USD | 2019万 USD | 2556.7万 USD | 3505万 USD | 3207.5万 USD |
| 受取利息 | — | — | — | 8.9万 USD | 11.7万 USD |
| 支払利息 | — | — | — | — | 1.4万 USD |
| 減価償却費と償却費 | 130.9万 USD | 58.1万 USD | 62.1万 USD | 66.9万 USD | 73.3万 USD |
| 営業利益 | −1989.4万 USD | −1117.1万 USD | −1729.6万 USD | −2503.1万 USD | −1947.1万 USD |
| 純利益 | −2123万 USD | −1113.6万 USD | −1358.3万 USD | −2384.5万 USD | −2028.8万 USD |
会社概要が更新されました 2026年10月17日.
発表済み実績と利用可能なコンセンサス予想。
発表済み実績と利用可能なコンセンサス予想。
第三者のアナリスト予想は変更される場合があり、GoAIの推奨ではありません。
この株式へのエクスポージャーを報告している上場投資信託です。
AIが生成した遅延市場データを、情報提供および教育目的で掲載しています。投資助言ではありません。
